Larvol Delta - BioSenic-releases-new-indepth-analysis-of-its-positive-phase-2-clinical-data-for-optimal-administration-scheme-for-its-next-latestage-trial-of-arsenic-trioxide-ATO-targeting-cGvHD

ArsciCor (arsenic trioxide oral) - BioSenic

https://www.globenewswire.com/news-release/2024/07/18/2915008/0/en/BioSenic-releases-new-in-depth-analysis-of-its-positive-phase-2-clinical-data-for-optimal-administration-scheme-for-its-next-late-stage-trial-of-arsenic-trioxide-ATO-targeting-cGvH.html

Jul 18, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next